Le Lézard
Classified in: Health
Subjects: SVY, SCZ

January Results From the Clover Health Flu Shot Monitor Reveal That Only 63% of U.S. Seniors Have Been Immunized This Season


SAN FRANCISCO, Jan. 14, 2019 /PRNewswire/ -- Today, newly conducted survey results from the January Clover Health Flu Shot Monitor reveal that only 63% of U.S. seniors 60 and older have gotten a flu shot so far this season. This is a negligible improvement from last month's findings, which showed that just 60% of adults 60 and older had been vaccinated.

(PRNewsfoto/Clover Health)

As the height of flu season nears, the latest Flu Shot Monitor results are prompting the Medicare Advantage insurer to urge all older Americans to get vaccinated immediately.

The most recent Clover Health Flu Shot Monitor also found that:

According to the CDC, flu season typically peaks in February, though flu activity has stretched into May in recent years. However, far fewer people report getting vaccinated against the flu past late November ? a dangerous trend, especially for senior citizens.

"Even in January, it's not too late for seniors to get a flu shot," said Kumar Dharmarajan, MD, Chief Scientific Officer, Clover Health. "It takes two weeks for the flu vaccine to take effect, making it crucial for older adults to get vaccinated as soon as possible before the flu hits its peak this season."

The monthly Flu Shot Monitor from Clover, a healthcare company using technology to improve medical outcomes, surveyed seniors across the U.S. to track the percentage of adults 60 and older who get vaccinated throughout this flu season.

Clover's focus on reducing the number of seniors who catch the flu stems from the company's commitment to preventative healthcare, leveraging data and its technology platform to proactively address potential illnesses before they become serious. As part of this, Clover's sophisticated technology has an 85% accuracy rate in identifying patients at risk of being admitted to the hospital in the next 28 days ? an unmatched level of precision.

As opposed to traditional fee-for-service that focuses on "sick care," Medicare Advantage insurers like Clover often offer a range of preventative care benefits, such as gym memberships, dental coverage, and home visits. Clover members also receive free flu shots as part of its comprehensive plan benefits.

The January Clover Health Flu Shot Monitor was conducted by Wakefield Research of 1,000 adults 60+ throughout the U.S.

About Clover Health
Clover Health is a healthcare technology company with a deeply-rooted mission of helping its members live their healthiest lives. Clover uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. As the only company whose business goals fully align with its members' health needs, Clover works with members and their doctors to become a valued partner. This trust is built by proactively identifying at-risk individuals and teaming up with providers to accelerate care coordination and simultaneously improve health outcomes and reduce avoidable costs. Clover is headquartered in San Francisco. For more information, visit www.cloverhealth.com.

Media Contacts:
Andrew Still-Baxter
[email protected]
406-250-8397

Michele Mendelson
[email protected]
646-747-7163

 

SOURCE Clover Health


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: